Microsoft, Alphabet and Goldman Sachs object to tokenized shares on OKXICE

Three of the largest U.S. corporations have told OKXICE they do not want tokenized versions of their shares traded on the venue. For BlockWest readers, the growing objector list tests how much of the SEC’s tokenized-stock framework issuers can veto in practice.

• Microsoft, Alphabet and Goldman Sachs are among seven new issuers objecting to tokenized shares on OKXICE.
• The disclosed tally of objecting companies reached 16, up from nine in the earlier public notice.
• Watch whether the 47 rostered companies without a disclosed objection stay silent under the SEC’s five-year Innovation Exemption.

• 16 issuers with disclosed objections, up from nine in the earlier notice
• 47 rostered companies without a disclosed objection, out of 62 originally listed
• 63 tickers in OKXICE’s original notice, representing 62 companies
• 5-year length of the SEC Innovation Exemption OKXICE seeks to operate under

Microsoft, Alphabet and Goldman Sachs have objected to tokenized versions of their shares trading on OKXICE, the planned venue from crypto exchange OKX and New York Stock Exchange parent Intercontinental Exchange (ICE), CoinDesk reported. The three are among seven additional objectors.

The updated public notice, dated Monday (October 19), lifts the disclosed total to 16 companies, from nine in the earlier notice. The document does not explain their reasons or specify when they submitted their objections.

Objections now cover 15 of the 62 companies OKXICE listed

OKXICE’s original notice identified 63 tickers representing 62 companies, with Alphabet appearing through both share classes. Fifteen of those companies have now objected, leaving 47 without a disclosed objection. That puts roughly a quarter of the proposed roster on record as objecting.

The seven new names are Microsoft (MSFT), Alphabet (GOOG, GOOGL), Goldman Sachs (GS), Qualcomm (QCOM), Caterpillar (CAT), McDonald’s (MCD) and Western Digital (WDC).

The tally is a hurdle for the SEC’s new framework for tokenized stock trading, which was unveiled last month. That framework allows issuers to block venues from offering blockchain-based versions of their shares.

Cerebras is the only objector outside OKXICE’s original roster

Cerebras Systems (CBRS) is the other objecting issuer, and it was not on the original proposed trading roster. The count of 16 is therefore 15 roster companies plus Cerebras.

Earlier objectors were Broadcom (AVGO), Verizon (VZ), UnitedHealth (UNH), CoreWeave (CRWV), AppLovin (APP), Applied Digital (APLD), Rocket Lab (RKLB) and Applied Optoelectronics (AAOI). Those nine, including Cerebras, made up the nine in the earlier notice.

OKXICE’s October 5 plan rests on the SEC’s five-year Innovation Exemption

OKXICE announced its plans on October 5, seeking to operate under the SEC’s five-year “Innovation Exemption.” The framework allows qualifying venues to trade tokenized U.S. stocks through automated market makers and liquidity pools, while giving issuers an opportunity to object.

The venue plans round-the-clock, stablecoin-settled trading of tokens backed one-for-one by shares. Those tokens would carry equivalent dividend and voting rights.

The reporting includes no comment from the objecting companies, OKX or ICE. Only the notice’s list of names is on the record, so each issuer’s position beyond the objection itself is unstated.

The BlockWest read. We read the objections as a contest over who controls the listing decision. Because issuers hold the opt-out, OKXICE’s usable roster is set by the companies, not by the venue. Large names such as Microsoft and Goldman Sachs removing themselves narrows what an allocator could access at launch. The venue’s liquidity plan now depends on the 47 names that have stayed quiet.

The open question is whether the next update to OKXICE’s public notice adds names to the 16, and whether any objecting issuer explains its reasons, which the current notice does not.

BlockWest is a news publication. Nothing here is investment advice. Read our disclaimer and editorial policy.